MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.420
-0.020 (-1.39%)
At close: Jul 31, 2026, 4:00 PM EDT
1.430
+0.010 (0.70%)
After-hours: Jul 31, 2026, 7:34 PM EDT
MetaVia Market Cap
MetaVia has a market cap or net worth of $7.33 million as of July 31, 2026. Its market cap has decreased by -38.13% in one year.
Market Cap
7.33M
Enterprise Value
-6.21M
1-Year Change
-38.13%
Ranking
Category
Stock Price
$1.42
ChartMarket Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $7.33M, a decrease of -99.99%. That is a compound annual growth rate of -76.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 7.33M | -60.44% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 7.87M |
| Niki BioSolutions | 7.85M |
| Bolt Biotherapeutics | 7.69M |
| AEON Biopharma | 7.23M |
| CNS Pharmaceuticals | 7.16M |
| Adial Pharmaceuticals | 7.15M |
| Can-Fite BioPharma | 6.91M |
| Traws Pharma | 6.89M |